BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Toll-like receptor 2 (TLR2); TLR1; TLR6

May 7, 2015 7:00 AM UTC

In vitro and mouse studies suggest an inhibitor of TLR2 signaling could help treat inflammatory diseases. In silico modeling of more than one million compounds binding the 3D structure of the intracel...